New Strategies for the Implementation and Support of Bioanalysis in a Drug Metabolism Environment

Integrated Strategies for Drug Discovery Using Mass Spectrometry

Volumn , Issue , 2005, Pages 359-377

  Korfmacher, Walter A ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Drug metabolism (DM) environment and matrix ion suppression; High throughput bioanalytical support; Triple quadrupole HPLC MS MS system

Indexed keywords

EID: 84889489376     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/0471721034.ch12     Document Type: Chapter

References (63)

1. Ackermann, B.L.; Berna, M.J.; Murphy, A.T. "Recent Advances in Use of LC/MS/MS for Quantitative High-Throughput Bioanalytical Support of Drug Discovery," Curr. Top. Med. Chem. 2(1), 53-66 (2002).
2. Jemal, M. "High-Throughput Quantitative Bioanalysis by LC/MS/MS," Biomed. Chromatogr. 14(6), 422-429 (2000).
3. Korfmacher, W.A.; Cox, K.A.; Bryant, M.S.; Veals, J.; Ng, K.; Lin, C.C. "HPLCAPI/MS/MS: A Powerful Tool for Integrating Drug Metabolism into the Drug Discovery Process," Drug Discov. Today 2, 532-537 (1997).
4. Riley, R.J.; Martin, I.J.; Cooper, A.E. "The Influence of DMPK as an Integrated Partner in Modern Drug Discovery," Curr. Drug Metab. 3(5), 527-550 (2002).
5. Thompson, T.N. "Early ADME in Support of Drug Discovery: The Role of Metabolic Stability Studies," Curr. Drug Metab. 1(3), 215-241 (2000).
6. Thompson, T.N. "Optimization of Metabolic Stability as a Goal of Modern Drug Design," Med. Res. Rev. 21(5), 412-449 (2001).
7. Kumar, G.N.; Surapaneni, S. "Role of Drug Metabolism in Drug Discovery and Development," Med. Res. Rev. 21(5), 397-411 (2001).
8. Chaturvedi, P.R.; Decker, C.J.; Odinecs, A. "Prediction of Pharmacokinetic Properties Using Experimental Approaches During Early Drug Discovery," Curr. Opin. Chem. Biol. 5(4), 452-463 (2001).
9. Eddershaw, P.J.; Beresford, A.P.; Bayliss, M.K. "ADME/PK as Part of a Rational Approach to Drug Discovery," Drug Discov. Today 5(9), 409-414 (2000).
10. Tarbit, M.H.; Berman, J. "High-Throughput Approaches for Evaluating Absorption, Metabolism and Excretion Properties of Lead Compounds," Curr. Opin. Chem. Biol. 2, 411-416 (1998).
11. Kennedy, T. "Managing the Drug Discovery/Developmement Interface," Drug Dis. Today 2(10), 436-444 (1997).
12. Roberts, S.A. "High-Throughput Screening Approaches for Investigating Drug Metabolism and Pharmacokinetics," Xenobiotica 31(8-9), 557-589 (2001).
13. Masimirembwa, C.M.; Thompson, R.; Andersson, T.B. "In Vitro High Throughput Screening of Compounds for Favorable Metabolic Properties in Drug Discovery," Comb. Chem. High Throughput Screen. 4(3), 245-263 (2001).
14. Korfmacher, W.A.; Palmer, C.A.; Nardo, C.; Dunn-Meynell, K.; Grotz, D.; Cox, K.; Lin, C.C.; Elicone, C.; Liu, C.; Duchoslav, E. "Development of an Automated Mass Spectrometry System for the Quantitative Analysis of Liver Microsomal Incubation Samples:ATool for Rapid Screening of NewCompounds for Metabolic Stability," Rapid Commun. Mass Spectrom. 13(10), 901-907 (1999).
15. Xu, R.; Nemes, C.; Jenkins, K.M.; Rourick, R.A.; Kassel, D.B.; Liu, C.Z. "Application of Parallel Liquid Chromatography/Mass Spectrometry for High Throughput Microsomal Stability Screening of Compound Libraries," J. Am. Soc. Mass Spectrom. 13(2), 155-165 (2002).
16. Bertrand, M.; Jackson, P.; Walther, B. "Rapid Assessment of Drug Metabolism in the Drug Discovery Process," Eur. J. Pharm. Sci. 11 (Suppl 2), S61-S72 (2000).
17. Hop, C.E.; Tiller, P.R.; Romanyshyn, L. "In Vitro Metabolite Identification Using Fast Gradient High Performance Liquid Chromatography Combined with Tandem Mass Spectrometry," Rapid Commun. Mass Spectrom. 16(3), 212-219 (2002).
18. Tiller, P.R.; Romanyshyn, L.A. "Liquid Chromatography/Tandem Mass Spectrometric Quantification with Metabolite Screening as a Strategy to Enhance the Early Drug Discovery Process," Rapid Commun. Mass Spectrom. 16(12), 1225-1231 (2002).
19. Clarke, N.J.; Rindgen, D.; Korfmacher, W.A.; Cox, K.A. "Systematic LC/MS Metabolite Identification in Drug Discovery," Anal. Chem. 73(15), 430A-439A (2001).
20. Gu, M.; Lim, H.K. "An Intelligent Data Acquisition System for Simultaneous Screening of Microsomal Stability and Metabolite Profiling by Liquid Chromatography/Mass Spectrometry," J. Mass Spectrom. 36(9), 1053-1061 (2001).
21. Lim, H.K.; Chan, K.W.; Sisenwine, S.; Scatina, J.A. "Simultaneous Screen for Microsomal Stability and Metabolite Profile by Direct Injection Turbulent-Laminar Flow LC-LC and Automated Tandem Mass Spectrometry," Anal. Chem. 73(9), 2140-2146 (2001).
22. Cox, K.A.; Clarke, N.J.; Rindgen, D.; Korfmacher, W.A. "Higher Throughput Metabolite Identification in Drug Discovery: Current Capabilities and Future Trends," Amer. Pharm. Rev. 4(1), 45-52 (2001).
23. Hidalgo, I.J. "Assessing the Absorption of New Pharmaceuticals," Curr. Top. Med. Chem. 1(5), 385-401 (2001).
24. Burton, P.S.; Goodwin, J.T.; Vidmar, T.J.; Amore, B.M. "Predicting Drug Absorption: How Nature Made It a Difficult Problem," J. Pharmacol. Exp. Ther. 303(3), 889-895 (2002).
25. Wang, Z.; Hop, C.E.; Leung, K.H.; Pang, J. "Determination of InVitro Permeability of Drug Candidates through a Caco-2 Cell Monolayer by Liquid Chromatography/Tandem Mass Spectrometry," J. Mass Spectrom. 35(1), 71-76 (2000).
26. Larger, P.; Altamura, M.; Catalioto, R.M.; Giuliani, S.; Maggi, C.A.; Valenti, C.; Triolo, A. "Simultaneous LC-MS/MS Determination of Reference Pharmaceuticals as a Method for the Characterization of the Caco-2 Cell Monolayer Absorption Properties," Anal. Chem. 74(20), 5273-5281 (2002).
27. Markowska, M.; Oberle, R.; Juzwin, S.; Hsu, C.P.; Gryszkiewicz, M.; Streeter, A.J. "Optimizing Caco-2 Cell Monolayers to Increase Throughput in Drug Intestinal Absorption Analysis," J. Pharmacol. Toxicol. Methods 46(1), 51-55 (2001).
28. Tannergren, C.; Langguth, P.; Hoffmann, K.J. "Compound Mixtures in Caco-2 Cell Permeability Screens as a Means to Increase Screening Capacity," Pharmazie 56(4), 337-342 (2001).
29. Lipinski, C.A. "Drug-Like Properties and the Causes of Poor Solubility and Poor Permeability," J. Pharmacol. Toxicol. Methods 44(1), 235-249 (2000).
30. Lipinski, C.A.; Lombardo, F.; Dominy, B.W.; Feeney, P.J. "Experimental and Computational Approaches to Estimate Solubility and Permeability in Drug Discovery and Development Settings," Adv. Drug Deliv. Rev. 46(1-3), 3-26 (2001).
31. Naritomi, Y.; Terashita, S.; Kimura, S.; Suzuki, A.; Kagayama, A.; Sugiyama, Y. "Prediction of Human Hepatic Clearance from In Vivo Animal Experiments and In Vitro Metabolic Studies with Liver Microsomes from Animals and Humans," Drug Metab. Dispos. 29(10), 1316-1324 (2001).
32. Mandagere, A.K.; Thompson, T.N.; Hwang, K.K. "Graphical Model for Estimating Oral Bioavailability of Drugs in Humans and Other Species from Their Caco-2 Permeability and In Vitro Liver Enzyme Metabolic Stability Rates," J. Med. Chem. 45(2), 304-311 (2002).
33. Wang, G.; Hsieh, Y.; Lau, Y.; Cheng, K.C.; Ng, K.;Korfmacher, W.A.; White, R.E. "Semi-Automated Determination of Plasma Stability of Drug Discovery Compounds Using Liquid Chromatography-Tandem Mass Spectrometry," J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 780(2), 451-457 (2002).
34. Wang, G.; Hsieh, Y. "Utilization of Direct HPLC-MS-MS for Drug Stability Measurement," Am. Lab. 34(24), 24-27 (2002).
35. Yan, Z.; Caldwell, G.W. "Metabolism Profiling, and Cytochrome P450 Inhibition and Induction in Drug Discovery," Curr. Top. Med. Chem. 1(5), 403-425 (2001).
36. Chu, I.; Favreau, L.; Soares, T.; Lin, C.; Nomeir, A.A. "Validation of Higher-Throughput High-Performance Liquid Chromatography/Atmospheric Pressure Chemical Ionization Tandem Mass Spectrometry Assays to Conduct Cytochrome P450s CYP2D6 and CYP3A4 Enzyme Inhibition Studies in Human Liver Microsomes," Rapid Commun. Mass Spectrom. 14(4), 207-214 (2000).
37. Testino, S.A., Jr.; Patonay, G. "High-Throughput Inhibition Screening of Major Human Cytochrome P450 Enzymes Using an In Vitro Cocktail and Liquid Chromatography-Tandem Mass Spectrometry," J. Pharm. Biomed. Anal. 30(5), 1459-1467 (2003).
38. Cox, K.A.; White, R.E.;Korfmacher, W.A. "Rapid Determination of Pharmacokinetic Properties of New Chemical Entities: In Vivo Approaches," Comb. Chem. High Throughput Screen. 5(1), 29-37 (2002).
39. O'Connor, D. "Automated Sample Preparation and LC-MS for High-Throughput ADME Quantification," Curr. Opin. Drug Disc. Devel. 5(1), 52-58 (2002).
40. Zell, M.; Husser, C.; Hopfgartner, G. "Column-Switching High-Performance Liquid Chromatography Combined with Ionspray Tandem Mass Spectrometry for the Simultaneous Determination of the Platelet Inhibitor Ro 44-3888 and Its Pro-Drug and Precursor Metabolite in Plasma," J. Mass Spectrom. 32(1), 23-32 (1997).
41. Zeng, H.; Wu, J.T.; Unger, S.E. "The Investigation and the Use of High Flow Column-Switching LC/MS/MS as a High-Throughput Approach for Direct Plasma Sample Analysis of Single and Multiple Components in Pharmacokinetic Studies," J. Pharm. Biomed. Anal. 27(6), 967-982 (2002).
42. Powell, M.L.; Jemal, M. "Rapid Chromatography Coupled with Direct Injection Lc/Ms/Ms for Quantitative Bioanalysis," Am. Pharm. Rev. 4(3), 63-69 (2001).
43. Ackermann, B.L.; Murphy, A.T.; Berna, M.J. "The Resurgence of Column Switching Techniques to Facilitate Rapid LC/MS/MS Based Bioanalysis in Drug Discovery," Am. Pharm. Rev. 5(1), 54-63 (2002).
44. Hopfgartner, G.; Husser, C.; Zell, M. "High-Throughput Quantification of Drugs and Their Metabolites in Biosamples by LC-MS/MS and CE-MS/MS: Possibilities and Limitations," Ther. Drug Monit. 24(1), 134-143 (2002).
45. Hsieh, Y.; Brisson, J.M.; Ng, K.; Korfmacher, W.A. "Direct Simultaneous Determination of Drug Discovery Compounds in Monkey Plasma Using Mixed-Function Column Liquid Chromatography/Tandem Mass Spectrometry," J. Pharm. Biomed. Anal. 27(1-2), 285-293 (2002).
46. Hsieh, Y.; Brisson, J.M.; Ng, K.; White, R.E.; Korfmacher, W.A. "Direct Simultaneous Analysis of Plasma Samples for a Drug Discovery Compound and Its Hydroxyl Metabolite Using Mixed-Function Column Liquid Chromatography-Tandem Mass Spectrometry," Analyst 126(12), 2139-2143 (2001).
47. Hsieh, Y.; Bryant, M.S.; Brisson, J.M.; Ng, K.; Korfmacher, W.A. "Direct Cocktail Analysis of Drug Discovery Compounds in Pooled Plasma Samples Using Liquid Chromatography-Tandem Mass Spectrometry," J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 767(2), 353-362 (2002).
48. Hsieh, Y.; Bryant, M.S.; Gruela, G.; Brisson, J.M.; Korfmacher, W.A. "Direct Analysis of Plasma Samples for Drug Discovery Compounds Using Mixed-Function Column Liquid Chromatography Tandem Mass Spectrometry," Rapid Commun. Mass Spectrom. 14(15), 1384-1390 (2000).
49. Hsieh, Y.; Ng, K.; Korfmacher, W. "Development and Application of Single-Column Direct Plasma Injection Procedures for Drug Candidate Assays Using HPLC-MS/MS," Am. Pharm. Rev. 5(4), 88-93 (2002).
50. Hsieh, Y.; Wang, G.; Wang, Y.; Chackalamannil, S.; Korfmacher, W.A. "Direct Plasma Analysis of Drug Compounds Using Monolithic Column Liquid Chromatography and Tandem Mass Spectrometry," Anal. Chem. 75(8), 1812-1818 (2003).
51. Olah, T.V.; McLoughlin, D.A.; Gilbert, J.D. "The Simultaneous Determination of Mixtures of Drug Candidates by Liquid Chromatography/Atmospheric Pressure Chemical Ionization Mass Spectrometry as an In Vivo Drug Screening Procedure," Rapid Commun. Mass Spectrom. 11(1), 17-23 (1997).
52. Berman, J.; Halm, K.; Adkison, K.; Shaffer, J. "Simultaneous Pharmacokinetic Screening of a Mixture of Compounds in the Dog Using API LC/MS/MS Analysis for Increased Throughput," J. Med. Chem. 40(6), 827-829 (1997).
53. Cox, K.A.; Dunn-Meynell, K.; Korfmacher, W.A.; Broske, L.; Nomeir, A.A.; Lin, C.C.; Cayen, M.N.; Barr, W.H. "Novel Procedure for Rapid Pharmacokinetic Screening of Discovery Compounds in Rats," Drug Disc. Today 4(5), 232-237 (1999).
54. Hop, C.E.; Wang, Z.; Chen, Q.; Kwei, G. "Plasma-Pooling Methods to Increase Throughput for In Vivo Pharmacokinetic Screening," J. Pharm. Sci. 87(7), 901-903 (1998).
55. Korfmacher, W.A.; Cox, K.A.; Ng, K.J.; Veals, J.; Hsieh, Y.; Wainhaus, S.; Broske, L.; Prelusky, D.; Nomeir, A.; White, R.E. "Cassette-Accelerated Rapid Rat Screen: A Systematic Procedure for the Dosing and Liquid Chromatography/Atmospheric Pressure Ionization Tandem Mass Spectrometric Analysis of New Chemical Entities as Part of New Drug Discovery," Rapid Commun. Mass Spectrom. 15(5), 335-340 (2001).
56. Papac, D.I.; Shahrokh, Z. "Mass Spectrometry Innovations in Drug Discovery and Development," Pharm. Res. 18(2), 131-145 (2001).
57. White, R.E.; Manitpisitkul, P. "Pharmacokinetic Theory of Cassette Dosing in Drug Discovery Screening," Drug Metab. Dispos. 29(7), 957-966 (2001).
58. King, R.; Bonfiglio, R.; Fernandez-Metzler, C.; Miller-Stein, C.; Olah, T. "Mechanistic Investigation of Ionization Suppression in Electrospray Ionization," J. Am. Soc. Mass Spectrom. 11(11), 942-950 (2000).
59. Zheng, J.J.; Lynch, E.D.; Unger, S.E. "Comparison of SPE and Fast LC to Eliminate Mass Spectrometric Matrix Effects from Microsomal Incubation Products," J. Pharm. Biomed. Anal. 28(2), 279-285 (2002).
60. Murphy, A.T.; Berna, M.J.; Holsapple, J.L.; Ackermann, B.L., "Effects of Flow Rate on High-Throughput Quantitative Analysis of Protein-Precipitated Plasma Using Liquid Chromatography/Tandem Mass Spectrometry," Rapid Commun. Mass Spectrom. 16(6), 537-543 (2002).
61. Muller, C.; Schafer, P.; Stortzel, M.;Vogt, S.;Weinmann, W. "Ion Suppression Effects in Liquid Chromatography-Electrospray-Ionisation Transport-Region Collision Induced Dissociation Mass Spectrometry with Different Serum Extraction Methods for Systematic Toxicological Analysis with Mass Spectra Libraries," J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 773(1), 47-52 (2002).
62. Tong, X.S.;Wang, J.; Zheng, S.; Pivnichny, J.V.; Griffin, P.R.; Shen, X.; Donnelly, M.;Vakerich, K.; Nunes, C.; Fenyk-Melody, J. "Effect of Signal Interference from Dosing Excipients on Pharmacokinetic Screening of Drug Candidates by Liquid Chromatography/Mass Spectrometry," Anal. Chem. 74(24), 6305-6313 (2002).
63. Mei, H.; Hsieh, Y.; Nardo, C.; Xu, X.; Wang, S.; Ng, K.; Korfmacher, W.A. "Investigation of Matrix Effects in Bioanalytical High-Performance Liquid Chromatography/Tandem Mass Spectrometric Assays: Application to Drug Discovery," Rapid Commun. Mass Spectrom. 17(1), 97-103 (2003).